首页 | 本学科首页   官方微博 | 高级检索  
     


Clinical Trials and Progress in Metastatic Colon Cancer
Affiliation:1. Gastrointestinal Cancer Program, Mayo Clinic Cancer Center, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, USA;2. Gastrointestinal Cancer Program, Mayo Clinic Cancer Center, Mayo Clinic Arizona, 5777 East Mayo Boulevard, Phoenix, AZ 85054, USA;1. Henry Ford Cancer Institute, 2799 West Grand Boulevard, Detroit, MI 48202, USA;2. Breast Oncology Program, Department of Surgery, Henry Ford Health System, Henry Ford Cancer Institute, International Center for the Study of Breast Cancer Subtypes, 2799 West Grand Boulevard, Detroit, MI 48202, USA;1. Peritoneal Surface Malignancies unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, Milano, Milan cap 20133, Italy;2. Surgical Oncology, MD Anderson Cancer Center, Calle Arturo Soria, n°270, Madrid, Spain;3. Department of General Surgery, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Weizmann Street 6, Tel Aviv, Israel;4. Department of Biotechnological and Applied Clinical Sciences, Università degli Studi dell''Aquila, Via Giovanni di Vincenzo, 16/B, L’Aquila, Italy;5. Colorectal Cancer unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, Milano, MI, cap 20133, Italy;1. Surgical Oncology Service, Department of General Surgery, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA;2. Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA;1. Surgical Oncology, Huntsman Cancer Institute, 2000 Circle of Hope Drive, Salt Lake City, UT 84112, USA;2. Division of Surgical Oncology, Department of Surgery, University of Massachusetts Medical School, 55 Lake Avenue N., Worcester, MA 01608, USA
Abstract:
Keywords:Colorectal cancer  Clinical trials  KRAS  BRAF  Her2  Immunotherapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号